Ticker Tape by TradingView
CanniMed Therapeutics is above all focused on providing pharmaceutical-grade products with an emphasis on quality control. The company was established in 2013 to provide Canadian patients with access to a standardized and trusted supply of pharmaceutical-grade cannabis. Currently we operate under the Access to Cannabis for Medical Purposes Regulations(ACMPR) governed by Health Canada. Our history is much deeper, however. From 2000 – 2013 our parent company, Prairie Plant Systems, was the sole supplier to Health Canada of medical cannabis. As a result of over a decade and a half of hands-on experience, we have implemented standard procedures and processes that are in line with pharmaceutical manufacturing standards to ensure consistency of our products for Canadian patients. For more information on CanniMed Therapeutics (CMED:TSX) please fill out the form below.